A detailed history of Forte Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Forte Capital LLC holds 3,963 shares of BMY stock, worth $157,172. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,963
Previous 4,023 1.49%
Holding current value
$157,172
Previous $206,000 3.88%
% of portfolio
0.03%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $2,878 - $3,264
-60 Reduced 1.49%
3,963 $214,000
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $47,413 - $56,577
-978 Reduced 19.56%
4,023 $206,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $7,236 - $8,091
-125 Reduced 2.44%
5,001 $290,000
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $34,467 - $38,270
-541 Reduced 9.55%
5,126 $327,000
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $54,099 - $64,061
790 Added 16.2%
5,667 $407,000
Q3 2022

Oct 21, 2022

BUY
$0.13 - $76.84 $73 - $43,491
566 Added 13.13%
4,877 $347,000
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $580 - $639
8 Added 0.19%
4,311 $332,000
Q4 2021

Jan 20, 2022

SELL
$53.63 - $62.52 $71,703 - $83,589
-1,337 Reduced 23.71%
4,303 $268,000
Q3 2021

Oct 27, 2021

BUY
$59.17 - $69.31 $2,189 - $2,564
37 Added 0.66%
5,640 $334,000
Q2 2021

Jul 28, 2021

BUY
$61.91 - $67.42 $11,886 - $12,944
192 Added 3.55%
5,603 $374,000
Q1 2021

Apr 22, 2021

SELL
$59.34 - $66.74 $53,524 - $60,199
-902 Reduced 14.29%
5,411 $342,000
Q4 2020

Jan 19, 2021

SELL
$57.74 - $65.43 $9,469 - $10,730
-164 Reduced 2.53%
6,313 $392,000
Q3 2020

Nov 03, 2020

SELL
$57.43 - $63.64 $9,246 - $10,246
-161 Reduced 2.43%
6,477 $391,000
Q2 2020

Jul 09, 2020

BUY
$54.82 - $64.09 $363,895 - $425,429
6,638 New
6,638 $390,000
Q4 2017

Jan 22, 2018

SELL
$59.94 - $65.35 $215,364 - $234,802
-3,593 Closed
0 $0
Q3 2017

Oct 11, 2017

BUY
$55.23 - $63.74 $198,441 - $229,017
3,593
3,593 $229,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Forte Capital LLC Portfolio

Follow Forte Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forte Capital LLC , based on Form 13F filings with the SEC.

News

Stay updated on Forte Capital LLC with notifications on news.